Skip to content
DraconiticResearch
Search Sources API
178,970 studies31 sourcesUpdated 27 min ago
Peer-reviewedCC BY 4.0Frontiers in Neuroscience

A representation-level wavelet–EMD fusion framework for spectral analysis and detection of epileptiform patterns in pediatric EEG: computational validation with a roadmap for external benchmarking

  1. 1Department of Pediatric Neurology and Respiratory Medicine, Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi City

Abstract

Background: Pediatric EEG analysis for epilepsy detection is challenged by the non-stationary and developmentally heterogeneous nature of epileptiform activity. Conventional Fourier approaches provide limited time–frequency localization, whereas single-domain methods such as the wavelet transform and empirical mode decomposition (EMD) each exhibit complementary weaknesses.

Methods: We developed a representation-level wavelet–EMD fusion framework that integrates wavelet and EMD spectra before feature extraction. The pipeline included adaptive wavelet denoising, energy-criterion EMD, weighted time–frequency fusion, extraction of eight spectral–temporal features, and classification using a soft-voting ensemble of a radial basis function support vector machine, random forest, and neural network. Evaluation was performed on 2,000 synthetic pediatric EEG segments spanning canonical epileptiform morphologies and multiple signal-to-noise ratios. A feature-level fusion variant was implemented as an ablation comparator to isolate the effect of fusion strategy while preserving identical feature extraction, classifier architecture, and validation procedures.

Results: Across 10-fold stratified cross-validation with 100 Monte Carlo replications, the proposed framework achieved 94.6 ± 0.6% accuracy, 93.7 ± 0.8% sensitivity, 95.5 ± 0.5% specificity, F1 score of 0.943 ± 0.007, and AUROC of 0.971 (95% CI, 0.962–0.978). Performance exceeded standalone wavelet, EMD, and Fourier baselines (all p < 0.001). Representation-level fusion also outperformed feature-level fusion by 1.4 percentage points in accuracy, with the greatest gains observed for polyspike and slow-wave morphologies. On the synthetic corpus the framework was competitive with EEGNet and a 1D convolutional network while retaining explicit time–frequency interpretability. In an external feasibility validation on the CHB-MIT pediatric scalp EEG corpus (14 subjects, leave-one-subject-out), representation-level fusion attained the highest performance of all methods (AUROC 0.901, accuracy 86.7%), confirming that the fusion strategy transfers to real recordings, with performance decreasing as expected.

Conclusion: Representation-level wavelet–EMD fusion provides an interpretable and transparent computational framework for analyzing non-stationary pediatric epileptiform EEG whose advantage over classical time–frequency baselines persists, at feasibility scale, on real CHB-MIT recordings and remains competitive with deep-learning baselines. Because the primary evaluation is synthetic and the external validation is a feasibility-scale demonstration, these figures should be read as evidence of methodological viability and external transportability rather than definitive clinical performance; validation on larger, multi-center and prospective pediatric cohorts is the essential next step.

Related

  1. ct-validation: an open framework for benchmarking target-indication evidence against clinical trial outcomes
    Klim Kostiuk, Daniel Igumnov, Peter Fedichev +1
    BioinformaticsPeer-reviewedCC BY 4.0Full textBioinformatics & computational biologyCrossrefPMC
  2. A mechanism-guided simulation framework for synthetic tax-risk data: Constraint validation and reproducible benchmarking
    Xiaojing Fan
    PLOS OnePeer-reviewedCC BY 4.0Full textCell biologyNeurosciencePLOS
  3. Benchmarking interface confidence as a selection criterion for computational nanobody design against survivin's BIR-domain groove
    C. Gately, X. Guan, X. Ding
    bioRxivPreprintCC BYFull textBioinformatics & computational biologybioRxiv
  4. RegDesign-Bench: Benchmarking computational methods for cell-type-specific regulatory DNA design
    J. Xu, Z. Guo, C. Zhong +6
    bioRxivPreprintCC BY-NC-NDFull textGenetics & genomicsbioRxiv
  5. BixBench3: Benchmarking AI agents on research-study-scale computational biology tasks
    Zane Koch, Asmamaw T. Wassie, Javier Valdes-Aleman +5
    arXivPreprintCC BY-SA 4.0Full textBioinformatics & computational biologyarXiv
BibTeX
@article{feng2026representationlevel,
  title = {{A representation-level wavelet–EMD fusion framework for spectral analysis and detection of epileptiform patterns in pediatric EEG: computational validation with a roadmap for external benchmarking}},
  author = {Dan Feng and Zhengtao Li},
  journal = {Frontiers in Neuroscience},
  year = {2026},
  month = oct,
  doi = {10.3389/fnins.2026.1884876},
  url = {https://www.frontiersin.org/articles/10.3389/fnins.2026.1884876/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A representation-level wavelet–EMD fusion framework for spectral analysis and detection of epileptiform patterns in pediatric EEG: computational validation with a roadmap for external benchmarking
AU  - Dan Feng
AU  - Zhengtao Li
PY  - 2026
DA  - 2026/10/14
JO  - Frontiers in Neuroscience
DO  - 10.3389/fnins.2026.1884876
UR  - https://www.frontiersin.org/articles/10.3389/fnins.2026.1884876/full
AB  - Background: Pediatric EEG analysis for epilepsy detection is challenged by the non-stationary and developmentally heterogeneous nature of epileptiform activity. Conventional Fourier approaches provide limited time–frequency localization, whereas single-domain methods such as the wavelet transform and empirical mode decomposition (EMD) each exhibit complementary weaknesses.  Methods: We developed a representation-level wavelet–EMD fusion framework that integrates wavelet and EMD spectra before feature extraction. The pipeline included adaptive wavelet denoising, energy-criterion EMD, weighted time–frequency fusion, extraction of eight spectral–temporal features, and classification using a soft-voting ensemble of a radial basis function support vector machine, random forest, and neural network. Evaluation was performed on 2,000 synthetic pediatric EEG segments spanning canonical epileptiform morphologies and multiple signal-to-noise ratios. A feature-level fusion variant was implemented as an ablation comparator to isolate the effect of fusion strategy while preserving identical feature extraction, classifier architecture, and validation procedures.  Results: Across 10-fold stratified cross-validation with 100 Monte Carlo replications, the proposed framework achieved 94.6 ± 0.6% accuracy, 93.7 ± 0.8% sensitivity, 95.5 ± 0.5% specificity, F1 score of 0.943 ± 0.007, and AUROC of 0.971 (95% CI, 0.962–0.978). Performance exceeded standalone wavelet, EMD, and Fourier baselines (all p < 0.001). Representation-level fusion also outperformed feature-level fusion by 1.4 percentage points in accuracy, with the greatest gains observed for polyspike and slow-wave morphologies. On the synthetic corpus the framework was competitive with EEGNet and a 1D convolutional network while retaining explicit time–frequency interpretability. In an external feasibility validation on the CHB-MIT pediatric scalp EEG corpus (14 subjects, leave-one-subject-out), representation-level fusion attained the highest performance of all methods (AUROC 0.901, accuracy 86.7%), confirming that the fusion strategy transfers to real recordings, with performance decreasing as expected.  Conclusion: Representation-level wavelet–EMD fusion provides an interpretable and transparent computational framework for analyzing non-stationary pediatric epileptiform EEG whose advantage over classical time–frequency baselines persists, at feasibility scale, on real CHB-MIT recordings and remains competitive with deep-learning baselines. Because the primary evaluation is synthetic and the external validation is a feasibility-scale demonstration, these figures should be read as evidence of methodological viability and external transportability rather than definitive clinical performance; validation on larger, multi-center and prospective pediatric cohorts is the essential next step.
SN  - 1662-453X
SN  - 1662-4548
ER  -